What Medis Medical Imaging does

Medis Medical Imaging Systems B.V. is a Netherlands-based, privately held developer of vendor-independent cardiac imaging analysis software, founded in 1989 and headquartered in Leiden. The company sells a portfolio of clinical software products organized around the Medis Suite platform — including Medis Suite MR, CT, XA, Ultrasound, and Intravascular modules — alongside Medis QFR, a standalone AI- and deep-learning-powered product for non-invasive coronary physiology assessment derived from angiography. Its technology supports quantitative analysis across CT, MRI, X-ray angiography, ultrasound, and intravascular (IVUS/OCT) modalities, with proprietary modules for strain analysis and Hemodynamic Forces (HDF) that derive intraventricular pressure gradients from standard images without invasive catheterization. Acquired IP from AMID anchors its speckle and feature tracking capabilities, and its algorithms are cited in more than 1,700 peer-reviewed publications.

Medis generates revenue primarily through subscription-based site licenses (annual or multi-year) sold via direct enterprise sales to hospitals, academic medical centers, and research institutions. Pricing is quote-based and not publicly disclosed, and the company offers free demos and product trials. Its go-to-market combines enterprise field sales with event-driven demand generation at major cardiovascular conferences (EuroPCR, TCT, ESC), complemented by KOL relationships and scientific publications. Products are regulatory cleared in the U.S. (FDA 510(k)), EU (CE under MDR 2017/745), Japan (PMDA), Canada, Australia (TGA), and South Korea (MFDS), and QFR carries a Class I recommendation in the 2024 ESC Guidelines for chronic coronary syndromes — providing multi-jurisdiction market access and clinical credibility. The customer base spans interventional cardiologists, cardiovascular imaging specialists, academic researchers, and cath lab technologists across more than 30 countries.

Name

Medis Medical Imaging

Legal name

Medis Medical Imaging Systems B.V.

Website

https://medisimaging.com

Company type

Private

Founded year

1990

Operating status

Operating

Headcount range

51–100 employees

Short description

Medis Medical Imaging is a Netherlands-based developer of vendor-independent cardiac imaging analysis software for CT, MRI, X-ray, ultrasound, and IVUS/OCT, serving interventional cardiologists, radiologists, and academic researchers globally with its AI-powered QFR platform.

Ownership category

akta.pro rank

Product category

Cardiac Imaging Software

NAICS

Surgical and Medical Instrument Manufacturing (339112), Software Publishers (5132)

SIC

Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

SaMD – Imaging & Signal Analysis (AI/ML) (HLACANAG)

akta.pro secondary industries

Hemodynamic Monitoring & Cardiac Diagnostics (Cath Lab, FFR/IVUS/OCT) (HLAHAFAI), AI Orchestration & Imaging Analytics Platforms (Model Management/Triage) (HLACALAG)

Keywords

• Cardiac imaging software
• Quantitative coronary analysis
• Medical imaging analytics
• Coronary physiology assessment
• Vascular imaging solutions

Headquarters

HQ city

Leiden

HQ country

Netherlands

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Software

Cost components

Technology or R&D, Personnel, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Medical Device Software Licenses: Medis generates revenue through licensing of FDA-cleared/regulatory-approved cardiac imaging software solutions to hospitals, research institutions, and healthcare facilities. Software is sold as annual or multi-year licenses with technical support.

Pricing tiers

Go-to-market motion2 records

Distribution channels2 records

Marketing channels6 records

Core offering

Medis Medical Imaging develops and sells vendor-independent cardiovascular imaging analysis software for hospitals, cath labs, and research institutions. Its portfolio includes the Medis QFR angiography-based coronary physiology product and the Medis Suite family of post-processing applications for MR, CT, XA, Ultrasound, and Intravascular imaging, delivered as subscription and site-license software.

Product overview

Medis Medical Imaging develops a comprehensive portfolio of cardiac imaging software solutions organized under the Medis Suite platform and standalone QFR product. The Medis Suite platform includes specialized solutions for different imaging modalities: Medis Suite MR (cardiac MRI analysis), Medis Suite CT (cardiovascular CT analysis), Medis Suite XA (X-ray angiography analysis), Medis Suite Ultrasound (cardiac ultrasound analysis), and Medis Suite Intravascular (IVUS and OCT analysis). Medis QFR® operates as a separate core product focused on non-invasive coronary physiology assessment using AI deep learning. The products share common analysis modules including strain analysis, hemodynamic forces assessment, and volumetric measurements, and are designed to be vendor-independent to work with imaging data from various equipment manufacturers. The portfolio supports cardiologists, radiologists, researchers, and industry partners in their clinical and research workflows.

Differentiator

Problem solved

Functional benefit

Brands

• Medis QFR: AI-powered non-invasive coronary physiology assessment software using Quantitative Flow Ratio technology for CT angiography.
• Medis Suite MR
• Medis Suite CT
• Medis Suite XA
• Medis Suite Ultrasound
• Medis Suite Intravascular

Products and services

• Medis QFR Quantitative Flow Ratio (QFR) software that performs AI/deep-learning–based 3D reconstruction and computational physiology analysis from routine coronary angiography, providing a non-invasive, catheter-free alternative to FFR for assessing the functional significance of coronary lesions. Used by interventional cardiologists in cath labs.
• Medis Suite MR Cardiovascular magnetic resonance (CMR) post-processing software that performs quantification of cardiac function, strain, flow, perfusion, and tissue characterization on MR images, intended for cardiologists, radiologists, and imaging core labs.
• Medis Suite CT Cardiac and vascular computed tomography post-processing software for calcium scoring, vessel analysis, plaque characterization, and 3D rendering, used by radiologists, cardiologists, and imaging researchers.
• Medis Suite XA X-ray angiography quantification software for 2D and 3D analysis of coronary and vascular structures during interventional procedures, used by interventional cardiologists and cath lab staff.
• Medis Suite Ultrasound Echocardiography post-processing software for 2D and 3D quantification of cardiac function, strain, and valve analysis, used by cardiologists and sonographers.
• Medis Suite Intravascular Intravascular imaging analysis software for IVUS and OCT pullbacks, enabling quantitative assessment of vessel morphology, plaque burden, and stent apposition, used by interventional cardiologists during and after PCI procedures.

Quantifiable outcome

• QFR-guided PCI demonstrated non-inferiority to usual-care PCI including FFR, iFR, IVUS, and OCT guidance in PIONEER IV trial real-world population
• +3 more outcomes

Named customers7 records

Segments4 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability4 records

Feature7 records

Partnerships

Seven partnerships are on record, tiered core.

• Radboud University Medical CentercoreStrategic or Co-development PartnerLong-term research collaboration spanning 20+ years. Radboud UMC serves as a reference site for Medis Suite MR development and validation. Dr. Robin Nijveldt collaborates on HDF research and clinical validation studies published in peer-reviewed journals.
• University of CaliforniacoreStrategic or Co-development PartnerDr. Morton J. Kern collaborates on Medis Suite MR research and development. UC serves as a key opinion leader site for product validation.
• Brigham Health / Brigham and Women's HospitalcoreStrategic or Co-development PartnerDr. Raymond Kwong uses Medis Suite XA for large-scale clinical trial research, contributing to product validation and real-world evidence generation.
• Goethe University FrankfurtcoreStrategic or Co-development PartnerDr. David M. Leistner collaborates on QFR clinical research and acute coronary syndrome applications. Key reference site for European market.
• Hospital Universitario German Trias i PujolcoreStrategic or Co-development PartnerVictoria Delgado, MD serves as KOL for Medis Suite CT and TAVI applications. Contributes to clinical evidence development and product feedback.
• University of TwentecoreStrategic or Co-development PartnerClemens von Birgelen, PD PhD collaborates on quantitative angiography research using Medis Suite XA, contributing to clinical trial evidence.
• AMID (Academia Medical Imaging Diagnostics)coreStrategic or Co-development PartnerMedis acquired AMID, the founders of strain imaging technology. AMID's speckle and feature tracking algorithms form the foundation of Medis' strain solution. This acquisition brought foundational IP and expertise in cardiac deformation analysis.

Scale indicators5 records

Recent moves6 records

Expansion highlights6 records

Emerging players

• Elucid Bioimaging: Elucid develops AI-based cardiovascular imaging analysis software for non-invasive plaque and vessel characterization, with overlapping applications to Medis's CT-based coronary analysis offerings.
• Cleerly: Cleerly applies AI to coronary CT angiography for plaque characterization and stenosis assessment, emerging as a competitor to Medis QFR and Medis Suite CT in AI-powered coronary analysis.
• Artrya: Artrya uses AI to analyze coronary CT angiography and identify at-risk plaques, an emerging direct competitor in the AI-driven cardiac CT analysis space where Medis Suite CT and QFR also operate.

Direct peers

• Pie Medical Imaging: Pie Medical Imaging (part of Esaote) develops quantitative cardiovascular analysis software for angiography and imaging, overlapping directly with Medis Suite XA in QCA and 3D-QCA bifurcation analysis.
• Circle Cardiovascular Imaging: Circle CVI provides CMR and CT cardiovascular post-processing software, directly competing with Medis Suite MR and Medis Suite CT in cardiac imaging analysis workflows for hospitals and research institutions.
• HeartFlow: HeartFlow is the leading non-invasive coronary physiology assessment company using CT-FFR (Fractional Flow Reserve derived from CT), the most direct competitor to Medis QFR. Both companies target interventional cardiologists and aim to replace wire-based invasive FFR.

Broad incumbents

• GE HealthCare (AW Workstation): GE Healthcare's AW Workstation provides cardiac analysis tools across CT and MR, competing with Medis Suite for hospital imaging post-processing workflows.
• Siemens Healthineers (syngo.via): Siemens syngo.via includes cardiac MR, CT, and XA analysis modules that compete with Medis Suite products, typically bundled with Siemens imaging equipment sales to hospitals.
• Philips TomTec: Philips acquired TomTec, a cardiac imaging analysis software vendor specializing in echocardiography and CMR/CT analysis, now embedded in Philips's broader cardiology portfolio. Direct overlap with Medis Suite MR, CT, and Ultrasound offerings.
• Canon Medical (Vitrea): Canon Medical's Vitrea advanced visualization workstation includes cardiac CT and MR analysis modules that compete with Medis Suite offerings in the cardiovascular post-processing market.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Medis Medical Imaging